Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose. 1976

J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh

A method for affinity chromatography of plasma and platelet factor XIII has been developed, based on known structural characteristics of these molecules. Plasma factor XIII is composed of a and b subunits which are held together by noncovalent interactions; platelet factor XIII has only a subunits. a subunit contains free sulfhydryl groups, while in b subunit all the cystines form disulfide bonds. The affinity gel is an organomercurial agarose with p-chloromercuribenzoate as the reactive group. Both the zymogen and activated forms of a subunit reversibly bind to the ligand by forming covalent mercaptide bonds and are eluted by reducing agents. b subunit does not bind to the affinity gel and is held to it only through interaction with a subunit. Affinity chromatography can be used to purify plasma and platelet factor XIII and to study interactions of the subunits. Experiments on the affinity chromatography of purified plasma factor XIII in several stages of activation agree with earlier observations that activation is a two-step procedure in which b subunit is not quantitatively released from the complex until the final stage of activation by Ca2+.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009941 Organomercury Compounds Organic compounds which contain mercury as an integral part of the molecule. Compounds, Organomercury
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D012685 Sepharose Agarose,Sepharose 4B,Sepharose C1 4B,4B, Sepharose C1,C1 4B, Sepharose
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular

Related Publications

J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
May 1977, Journal of biochemistry,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
December 1976, Thrombosis and haemostasis,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
April 1975, FEBS letters,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
November 1982, FEBS letters,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
January 1988, Ukrainskii biokhimicheskii zhurnal (1978),
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
September 1971, The Journal of biological chemistry,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
December 1990, Analytical chemistry,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
January 1976, The Journal of biological chemistry,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
August 1975, Thrombosis research,
J Mcdonagh, and W G Waggoner, and E G Hamilton, and B Hindenbach, and R P Mcdonagh
June 2006, CSH protocols,
Copied contents to your clipboard!